Applications of the Insieme Platform: A Case Study
DOI:
https://doi.org/10.31449/inf.v46i4.4210Abstract
The information society has significantly changed the field of medicine. Several decades ago when a person got sick, a doctor examined a patient and prescribed some medicine with a patient more or less unaware of the true nature of the problem. Even if explained, many patients did not understand much due to the lack of medical knowledge. Today, knowledge is widely accessible through the web and many patients try to self-diagnose or at least get another opinion using popular search engines and specialized web applications. However, many of them provide misinformation due to the lack of proper education of the provider or the lack of understanding of the user. To overcome these issues, we developed a verified medical platform (Insieme platform) that includes medical data, applications and services. This article provides a list of applications in the Insieme platform, their descriptions and how to use them.References
ISE-EMH project, Insieme platform, https://ise-emh.eu/. Accessed July 11, 2022.
EkoSMART, https://feri.um.si/raziskovanje/ mednarodni-projekti-in-projekti-strukturnih-skladov/ekosistem-pametnega-mesta/. Accessed July 11, 2022.
Clynx, Motiphy+ application, https://www.clynx.io/. Accessed May 10, 2022.
Robotina, HEMS, https://mailchi.mp/robotina/ise-emh_elderly_hems_data_services. Accessed May 10, 2022.
DaVinci Biolab app, DaVinci, https://davinci.biohub.solutions/. Accessed May 10, 2022.
Platomics, Platomics application Biolab, https://davinci.biohub.solutions/platomics/. Accessed May 10, 2022.
Depression application MoodTools, https://www.moodtools.org/. Accessed May 10, 2022.
Narcistic personal disorder test, Do I have a personal disorder?, https://www.therecoveryvillage.com/mental-health/personality-disorders/do-i-have-a-personality-disorder/. Accessed May 10, 2022.
Bigorexia, Body dysmphorphia quiz, https://eatingdisordersolutions.com/body-dysmorphic-eating-disorder-treatment/body-dysmorphia-quiz/. Accessed May 10, 2022.
Schizophrenia self-testing app, https://www.mind-diagnostics.org/schizophrenia-test. Accessed May 10, 2022.
Focus on Lymphoma web application, https://www.digiteum.com/portfolio/no-1-healthcare-app-for-lymphoma/. Accessed May 10, 2022.
Clayman Thyroid Center, Thyroid cancer application, https://www.thyroidcancer.com/app. Accessed May 10, 2022.
ASPO, https://aspo.mf.uni-lj.si/static/ASPO_new/#/. Accessed May 10, 2022.
HEP-Y, https://hepy.mf.uni-lj.si/static/HEPY_new/# /opisi-virusnihhepatitisov/description-hb. Accessed May 10, 2022.
Senior helper application for elderly, http://senior-helper-website.docker-e9.ijs.si/. Accessed May 10, 2022.
Nala-care, Neuro-dermatitis app, https://nala.care/en/. Accessed May 10, 2022.
Skin-vision, Skin cancer melanoma application, https://www.skinvision.com/. Accessed May 10, 2022.
SURS, Število in sestava prebivalstva, https://www.stat.si/StatWeb/Field/Index/17/104. Accessed May 10, 2022.
United nations, Our world is growing older, https://www.un.org/development/desa/en/news/population/our-world-is-growing-older.html. Accessed May 10, 2022.
A. J. Astell, M. Panouand K. Touliou, et al. (2022). Developing a pragmatic evaluation of ICTs for older adults with cognitive impairment at scale: the IN LIFE experience. Univ Access Inf Soc, vol. 21, pp. 1–19, https://doi.org/10.1007/s10209-021-00849-5.
J. Bizjak, A. Gradišek, L. Stepančič, H. Gjoreski, and M. Gams (2017). Intelligent assistant carer for active aging. EURASIP J. Adv. Signal Process, vol. 2017, no. 76, https://doi.org/10.1186/s13634-017-0511-y.
R. I. Putu. (2020). Integrated Scada-Tricoder: A Modern Hospital Room. https://doi.org/10.13140/RG.2.2.24385.38247.
N. M. Pereira-Azevedo and L. D. F. Venderbos (2018). eHealth and mHealth in prostate cancer detection and active surveillance. Transl Androl Urol, vol. 7, no. 1, pp. 170–181, https://doi.org/10.21037/tau.2017.12.22.
N. Pereira-Azevedo, J. F. M. Verbeek, D. Nieboer, C. H. Bangma, and M. J. Roobol (2018). Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome. Transl Androl Urol, vol. 7, no. 1, pp. 18–26, https://doi.org/10.21037/tau.2017.12.21.
N. Pereira-Azevedo, L. Osório, A. Fraga, and M. J. Roobol (2017). Rotterdam prostate cancer risk calculator: development and usability testing of the mobile phone app. JMIR Cancer, vol.3 no. 1, article no. e1, https://doi.org/10.2196/cancer.6750.
ScienceDaily, University of East Anglia, Prostate cancer urine test identifies good prognosis patients, www.sciencedaily.com/releases/2021/11/211102210147.htm. Accessed May 10, 2022.
D. Ilic, M. Djulbegovic, J. H. Jung, E. C. Hwang, Q. Zhou, A. Cleves, T. Agoritsas, and P. Dahm (2018). Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ, vol. 362, article no. k3519, https://doi.org/10.1136/bmj.k3519.
S. M. Lenherr and J. Quentin Clemenm (2013). Urodynamics: with a focus on appropriate indications. Urol Clin North Am, vol. 40, no. 4, pp. 545–557, https://doi.org/10.1016/j.ucl.2013.07.001.
C. J. Harvey, J. Pilcher, J. Richenberg, U. Patel, and F. Frauscher (2012). Applications of transrectal ultrasound in prostate cancer. Br J Radiol, vol. 85, pp. S3–S17, https://doi.org/10.1259/bjr/56357549.
S. F. Shariat and C. G. Roehrborn (2008). Using biopsy to detect prostate cancer. Rev Urol, vol. 10, no. 4, pp. 262–280.
Frequency of urinating, https://www.bladderandbowel.org/bladder/bladder-conditions-and-symptoms/frequency/. Accessed May 10, 2022.
A. Ajanović, J. Konda, G. Fele-Žorž, A. Gradišek, M. Gams, A. Peterlin, K. Počivavšek, M. Matičič (2017). Application for sexually transmitted infection risk assessment. Informatica, vol. 41, no. 2, pp. 253–254.
A. Ajanović, A. Ulčar, A. Petelin, K. Počivavšek, G. Fele-Žorž, A. Gradišek, M. Gams, and M. Matičič (2018). Application for viral hepatitis infection risk assessment - HEPY. Informatica, vol. 42, no. 2, pp. 279–281.
Downloads
Published
How to Cite
Issue
Section
License
I assign to Informatica, An International Journal of Computing and Informatics ("Journal") the copyright in the manuscript identified above and any additional material (figures, tables, illustrations, software or other information intended for publication) submitted as part of or as a supplement to the manuscript ("Paper") in all forms and media throughout the world, in all languages, for the full term of copyright, effective when and if the article is accepted for publication. This transfer includes the right to reproduce and/or to distribute the Paper to other journals or digital libraries in electronic and online forms and systems.
I understand that I retain the rights to use the pre-prints, off-prints, accepted manuscript and published journal Paper for personal use, scholarly purposes and internal institutional use.
In certain cases, I can ask for retaining the publishing rights of the Paper. The Journal can permit or deny the request for publishing rights, to which I fully agree.
I declare that the submitted Paper is original, has been written by the stated authors and has not been published elsewhere nor is currently being considered for publication by any other journal and will not be submitted for such review while under review by this Journal. The Paper contains no material that violates proprietary rights of any other person or entity. I have obtained written permission from copyright owners for any excerpts from copyrighted works that are included and have credited the sources in my article. I have informed the co-author(s) of the terms of this publishing agreement.
Copyright © Slovenian Society Informatika